Nyxoah S A (NYXH) Stock Price, Quote & News

Company Profile

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 32 1 022 23 55

Fax: 32 1 045 90 75

Website: www.nyxoah.com

Address:

Rue Edouard Belin 12, Mont-Saint-Guibert, Belgium

topstockalerts Mar. 20 at 6:01 PM

$NYXH newer ticker behavior, still in discovery mode. Can get volatile as traders figure out range.

0 · Reply

NathanWolffe Mar. 20 at 4:35 PM

Watching: $DRMA $EDSA $NYXH $JAGU $WNW

0 · Reply

StocktwitsEarnings Mar. 19 at 9:18 PM

$NYXH Q4 '25 Earnings Results & Recap Nyxoah anticipates U.S. net revenue to grow approximately 25% sequentially in both Q1 2026 over Q4 2025, and Q2 2026 over Q1 2026, with international revenue following a typical seasonal pattern.

0 · Reply

bartwood Mar. 16 at 1:53 PM

$NYXH

0 · Reply

mahesh_99 Mar. 15 at 7:05 PM

$NYXH

0 · Reply

Lilingpeace Mar. 10 at 5:58 PM

$NYXH started initial positions here, hopefully Genio will take off

0 · Reply

Lilwopjob Mar. 3 at 8:47 PM

Is $NYXH going to eat $INSPS lunch? Position in neither but I’ve been researching / watching a couples months.

0 · Reply

notreload_ai Feb. 26 at 7:46 PM

$INSP , $NYXH ... CMS resolves hypoglossal nerve stimulation reimbursement confusion by adding 6 new HCPCS codes (effective Jan 1, 2026), viewed as positive for Inspire & Nyxoah. https://notreload.xyz/cms-adds-hcpcs-codes-for-hgns-boost-for-inspire-nyxoah/

0 · Reply

InItToWinIt100 Feb. 26 at 7:25 PM

$NYXH Out of nowhere! https://www.trade-ideas.com/share.php?code=Gr0mz3StGd380SJnyduBog5jhQsmkku0

0 · Reply

OfficialStocktwitsUser Feb. 21 at 6:00 PM

$NYXH RSI: 43.90, MACD: -0.0625 Vol: 0.14, MA20: 4.67, MA50: 4.77 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East

Jan 21, 2026, 4:05 PM EST - 2 months ago

Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth

Jan 12, 2026, 1:00 AM EST - 2 months ago

Publication relating to transparency notification

Dec 19, 2025, 4:05 PM EST - 3 months ago

Nyxoah Announces Issuance of First Tranche of Convertible Bonds

Dec 17, 2025, 1:05 AM EST - 3 months ago

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands

Dec 2, 2025, 4:30 PM EST - 3 months ago

Publication relating to transparency notifications

Nov 27, 2025, 4:05 PM EST - 4 months ago

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 26, 2025, 1:45 AM EST - 4 months ago

Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule

Nov 20, 2025, 4:30 PM EST - 4 months ago

Information on the total number of voting rights and shares

Nov 13, 2025, 4:36 PM EST - 4 months ago

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

Nov 13, 2025, 4:12 PM EST - 4 months ago

Nyxoah Reports Third Quarter 2025 Financial and Operating Results

Nov 3, 2025, 4:05 PM EST - 4 months ago

Nyxoah to Participate in the Stifel 2025 Healthcare Conference

Oct 30, 2025, 5:10 PM EDT - 5 months ago

Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025

Oct 6, 2025, 1:00 AM EDT - 5 months ago

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System

Sep 23, 2025, 4:10 PM EDT - 6 months ago

Nyxoah Provides an Update on Expanded Middle East Presence

Sep 15, 2025, 4:10 PM EDT - 6 months ago

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

Sep 2, 2025, 4:30 PM EDT - 7 months ago

Nyxoah Announces Upcoming Investor Events

Aug 18, 2025, 4:10 PM EDT - 7 months ago

Nyxoah Reports Second Quarter Financial and Operating Results

Aug 11, 2025, 1:00 AM EDT - 7 months ago

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Aug 8, 2025, 4:10 PM EDT - 8 months ago

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

Jul 29, 2025, 4:30 PM EDT - 8 months ago

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

Jul 28, 2025, 4:05 PM EDT - 8 months ago

Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

Jun 13, 2025, 1:00 AM EDT - 10 months ago

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025

May 28, 2025, 4:30 PM EDT - 10 months ago

Nyxoah to Present at the Jefferies Global Healthcare Conference

May 14, 2025, 1:00 AM EDT - 11 months ago

Nyxoah Reports First Quarter Financial and Operating Results

May 9, 2025, 1:00 AM EDT - 11 months ago

Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025

Apr 22, 2025, 10:00 AM EDT - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Shareholders to Reach Out

Apr 21, 2025, 10:00 AM EDT - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Shareholders to Learn More About the Investigation

Apr 20, 2025, 10:00 AM EDT - 11 months ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Apr 18, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Shareholders to Inquire about Securities Investigation

Apr 17, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Investors to Connect

Apr 16, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Stockholders to Inquire about Securities Investigation

Apr 16, 2025, 2:00 AM EDT - 1 year ago

Conditional Issuance of Shares

Apr 15, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Investors to Learn More About the Investigation

Apr 14, 2025, 10:00 AM EDT - 1 year ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Apr 11, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Stockholders to Connect

Apr 10, 2025, 10:00 AM EDT - 1 year ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Apr 9, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Stockholders to Learn More About the Investigation

Apr 8, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Investors to Inquire about Securities Investigation

Apr 8, 2025, 1:00 AM EDT - 1 year ago

Nyxoah Provides Update on FDA Approvable Letter for Genio System

topstockalerts Mar. 20 at 6:01 PM

$NYXH newer ticker behavior, still in discovery mode. Can get volatile as traders figure out range.

0 · Reply

NathanWolffe Mar. 20 at 4:35 PM

Watching: $DRMA $EDSA $NYXH $JAGU $WNW

0 · Reply

StocktwitsEarnings Mar. 19 at 9:18 PM

0 · Reply

bartwood Mar. 16 at 1:53 PM

$NYXH

0 · Reply

mahesh_99 Mar. 15 at 7:05 PM

$NYXH

0 · Reply

Lilingpeace Mar. 10 at 5:58 PM

$NYXH started initial positions here, hopefully Genio will take off

0 · Reply

Lilwopjob Mar. 3 at 8:47 PM

Is $NYXH going to eat $INSPS lunch? Position in neither but I’ve been researching / watching a couples months.

0 · Reply

notreload_ai Feb. 26 at 7:46 PM

0 · Reply

InItToWinIt100 Feb. 26 at 7:25 PM

$NYXH Out of nowhere! https://www.trade-ideas.com/share.php?code=Gr0mz3StGd380SJnyduBog5jhQsmkku0

0 · Reply

OfficialStocktwitsUser Feb. 21 at 6:00 PM

0 · Reply

triggerzac Feb. 17 at 8:25 AM

$NYXH Obscure micro-cap; minimal coverage

0 · Reply

Amb8675309 Feb. 7 at 12:34 AM

$NYXH forgot I was holding this- what’s going on that it’s up? Too busy nursing my ITRM position

0 · Reply

OfficialStocktwitsUser Feb. 4 at 2:41 AM

$NYXH RSI: 26.36, MACD: -0.0347 Vol: 0.18, MA20: 4.90, MA50: 4.80 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

SuperGreenToday Jan. 22 at 10:34 PM

$NYXH

0 · Reply

Noobnr1 Jan. 13 at 5:39 AM

$NYXH 🚀 netto gain increases with 348% 👏 $PHAR $BEAM $OMER $GILD 💎

0 · Reply

TheVirus0011 Dec. 29 at 11:09 PM

$NYXH OMG ??????

0 · Reply

HoneyHedge Dec. 25 at 9:25 AM

$NYXH The valuation debate now centers on reliability of delivery, with macro volatility magnifying operational missteps. Momentum turns durable only after multiple confirmations.

0 · Reply

SuperGreenToday Dec. 19 at 6:10 PM

$NYXH

0 · Reply

OpenOutcrier Dec. 17 at 2:00 PM

$NYXH (+6.0% pre) New battery-free sleep apnea implant debuts in Dutch hospitals https://ooc.bz/l/87759

0 · Reply

islandpunk Dec. 17 at 6:50 AM

$NYXH https://www.stocktitan.net/news/NYXH/nyxoah-announces-commercial-launch-of-genio-breakthrough-therapy-in-l4glybk0sir9.html

0 · Reply

ZacksResearch Dec. 1 at 2:33 PM

$NYXH down 40% so far this year but could a CMS reimbursement boost improve prospects in 2026? 🔄 🩺 CPT Code 64568 rates up 48% for hospitals and 58% for ASCs in 2026 💸 New rates could drive adoption and expand Medicare-heavy institutions See how this could impact NYXH's future here 👉 https://www.zacks.com/stock/news/2797639/nyxoah-gains-favorable-cms-reimbursement-ruling-for-genio-system?cid=sm-stocktwits-2-2797639-body-22848&ADID=SYND_STOCKTWITS_TWEET_2_2797639_BODY_22848

0 · Reply

ZacksResearch Dec. 1 at 1:33 PM

Big win for $NYXH — this CMS ruling could be a real momentum catalyst. The finalized 2026 reimbursement for its Genio implants jumps sharply, giving its OSA therapy a much stronger commercial runway. See what this means for the setup 👉 https://www.zacks.com/stock/news/2797639/nyxoah-gains-favorable-cms-reimbursement-ruling-for-genio-system?cid=sm-stocktwits-2-2797639-teaser-22846&ADID=SYND_STOCKTWITS_TWEET_2_2797639_TEASER_22846

0 · Reply

Market Cap	104.22M
Revenue (ttm)	4.89M
Net Income (ttm)	-64.10M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,310.84%
Debt to Equity Ratio	0.37

Volume	160,700
Avg Vol	51,372
Day's Range	N/A - N/A
Shares Out	34.06M
Stochastic %K	11%
Beta	1.56
Analysts	Strong Sell
Price Target	$11.00